Company Atlasby Kadoa
Star on GitHub

AbbVie ABBV

AbbVie is the 19th largest S&P 500 company by market cap, worth $505 billion. 13 directors have filed with the SEC in the last 12 months (who counts), 1 of them an executive. 8 other officers are on file. At 30 Jun 2026, Vanguard was its largest institutional holder, with 10.3% of the company.

Chair and CEO
Robert A. Michael
Sector
Health Care
Sub-industry
Biotechnology
Headquarters
North Chicago, Illinois
Founded
1888
More
Wikipedia
Market cap
$505B
19th largest, 23 Oct 2026 close
Revenue
$61.2B
Fiscal year 2025
Price to sales
8.3
Market cap over revenue
Employees
57,000
10-K, 31 Dec 2025
Market cap per employee
$8.9M
Market cap over employees
Connections
6
S&P 500 companies sharing a director or officer

Largest institutional holders

Each fund group's share of AbbVie. Where a company has several share classes, the share is of its total value.

13F filings for the quarter to 30 Jun 2026

These five hold 29.9% of AbbVie.

Source: SEC Form 13F data sets, SEC XBRL shares outstanding 路 All holders

Board and officers

5 people here also hold roles at other S&P 500 companies.

Roles filed up to 30 Sep 2026

NameTitle
Directors (13)
Robert A. MichaelChairman of the Board and CEOLast filed 3 Mar 2026Chairman of the Board and CEO
Robert J. AlpernDirectorAlso at Abbott LaboratoriesDirector
Roxanne S. AustinDirectorAlso at CrowdStrike and VerizonDirector
William H.L. BurnsideDirectorDirector
Jennifer L. DavisDirectorDirector
Thomas J. FalkDirectorAlso at Lockheed MartinDirector
Thomas C. FreymanDirectorDirector
Brett J. HartDirectorAlso at United Airlines HoldingsDirector
Melody B. MeyerDirectorDirector
Susan E. QuagginDirectorDirector
Edward J. RappDirectorDirector
Rebecca B. RobertsDirectorDirector
Frederick H. WaddellDirectorAlso at IBMDirector
Officers (8)
Scott T. ReentsEVP, Chief Financial OfficerLast filed 3 Mar 2026EVP, Chief Financial Officer
Demetris D. CrumEVP, Chief HR OfficerLast filed 6 Mar 2026EVP, Chief HR Officer
Nicholas DonoghoeEVP, Chief Bus/Strat OfficerLast filed 18 Aug 2026EVP, Chief Bus/Strat Officer
David Ryan PurdueSVP, ControllerLast filed 11 Mar 2026SVP, Controller
Azita Saleki-GerhardtEVP, Chief Operations OfficerLast filed 3 Mar 2026EVP, Chief Operations Officer
Perry C. SiatisEVP, GC and SecretaryLast filed 3 Mar 2026EVP, GC and Secretary
Jeffrey Ryan StewartEVP, Chief Commercial OfficerLast filed 3 Mar 2026EVP, Chief Commercial Officer
Roopal ThakkarEVP, R&D and CSOLast filed 3 Mar 2026EVP, R&D and CSO

Source: SEC insider filings (Forms 3, 4 and 5), AbbVie's Form 4 filings 路 All directors and officers

Companies that share people with AbbVie

Each person's title here, then at the other company.

Source: SEC insider filings 路 See the whole network

AbbVie's market cap since January 2013

Marked weeks are changes in the share count, such as a merger, not market moves.

Weekly, up to 23 Oct 2026

Show equal percentage changes as equal steps.
2014201620182020202220242026$505B

Source: Yahoo Finance closing prices, SEC XBRL shares outstanding

Workforce

Headcount at 31 Dec 2025

Employees
57,000
EmployeesAbbVie employed approximately 57,000 employees in over 70 countries as of December 31, 2025.
AbbVie Form 10-K

Source: AbbVie Form 10-K

Insider trades

Open-market buys and sales by directors and officers. Grants, option exercises and shares withheld for tax are left out.

Trades from 30 Sep 2025 to 30 Sep 2026

Directors and officers sold $18.9 million of stock in 4 sales and made no open-market purchases in the 12 months to 30 Sep 2026.

DatePersonTitleTypeSharesValue
14 Aug 2026SaleNicholas DonoghoeEVP, Chief Bus/Strat OfficerEVP, Chief Bus/Strat OfficerSale32,710$8.2M
4 Mar 2026SaleDavid Ryan PurdueSVP, ControllerSVP, ControllerSale5,230$1.2M
2 Mar 2026SalePerry C. SiatisEVP, GC and SecretaryEVP, GC and SecretarySale18,668$4.4M
25 Feb 2026SalePerry C. SiatisEVP, GC and SecretaryEVP, GC and SecretarySale22,381$5.1M

Source: SEC insider transactions data sets, AbbVie's Form 4 filings

Trades by members of Congress and officials

Trades members of Congress and senior executive branch officials disclosed, including their families'. Amounts are filed as ranges.

Trades from 20 Oct 2023 to 20 Oct 2026

24 people disclosed 47 purchases and 51 sales of AbbVie stock since October 2023.

DateMember or officialTypeAmount
14 Sep 2026Pete Sessions (House, R-TX)House, R-TX 路 SoldSale$15,001 to $50,000$15K to $50K
4 Sep 2026Rohit Khanna (House, D-CA)House, D-CA 路 SoldSale$1,001 to $15,000$1K to $15K
31 Jul 2026Donald J Trump (President)President 路 BoughtPurchase$50,001 to $100,000$50K to $100K
23 Jul 2026Donald J Trump (President)President 路 BoughtPurchase$50,001 to $100,000$50K to $100K
23 Jun 2026Donald J Trump (President)President 路 BoughtPurchase$1,001 to $15,000$1K to $15K
16 Jun 2026Donald J Trump (President)President 路 BoughtPurchase$50,001 to $100,000$50K to $100K
12 Jun 2026Donald J Trump (President)President 路 BoughtPurchase$15,001 to $50,000$15K to $50K
18 May 2026Donald J Trump (President)President 路 SoldSale$100,001 to $250,000$100K to $250K
18 May 2026Donald J Trump (President)President 路 SoldSale$1,001 to $15,000$1K to $15K
15 May 2026Donald J Trump (President)President 路 BoughtPurchase$50,001 to $100,000$50K to $100K

Showing 10 of 98 trades

Source: House, Senate and OGE disclosures via the Congress trading monitor

WARN layoff notices

Notices filed under AbbVie's own name. Subsidiaries that file under their own names are not included.

Notices from 26 Oct 2023 to 26 Oct 2026

AbbVie filed 4 notices covering 144 workers since October 2023.

NoticePlaceWorkersEffective
19 May 2026Irvine, CA8520 Jul 2026
13 Nov 2025Dublin, CA489 Jan 2026
13 Nov 2025Livermore, CA99 Jan 2026
13 Nov 2025Pleasonton, CA29 Jan 2026

Source: State WARN notices via the US layoffs tracker